Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1988 |
100 Clinical Results associated with Tianjin Tianda Leading Pharmaceuticals Co. Ltd.
0 Patents (Medical) associated with Tianjin Tianda Leading Pharmaceuticals Co. Ltd.
100 Deals associated with Tianjin Tianda Leading Pharmaceuticals Co. Ltd.
100 Translational Medicine associated with Tianjin Tianda Leading Pharmaceuticals Co. Ltd.